as 12-17-2024 4:00pm EST
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.
Founded: | 1976 | Country: | United States |
Employees: | N/A | City: | FARMINGDALE |
Market Cap: | 56.4M | IPO Year: | N/A |
Target Price: | N/A | AVG Volume (30 days): | 198.0K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | Dividend Payout Frequency: | N/A | |
EPS: | -0.46 | EPS Growth: | N/A |
52 Week Low/High: | $0.68 - $1.50 | Next Earning Date: | 12-16-2024 |
Revenue: | $30,314,000 | Revenue Growth: | 2.72% |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
ENZ Breaking Stock News: Dive into ENZ Ticker-Specific Updates for Smart Investing
Associated Press Finance
2 days ago
GlobeNewswire
2 days ago
Zacks
13 days ago
Zacks
14 days ago
Simply Wall St.
15 days ago
Simply Wall St.
2 months ago
Simply Wall St.
2 months ago
Zacks
2 months ago
The information presented on this page, "ENZ Enzo Biochem Inc. ($0.01 Par Value) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.